149 related articles for article (PubMed ID: 19682862)
21. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
22. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice.
Domingo S; Gastearena I; Vitas AI; López-Goñi I; Dios-Viéitez C; Díaz R; Gamazo C
J Antimicrob Chemother; 1995 Oct; 36(4):647-56. PubMed ID: 8591939
[TBL] [Abstract][Full Text] [Related]
23. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
Johnson JL; Hadad DJ; Boom WH; Daley CL; Peloquin CA; Eisenach KD; Jankus DD; Debanne SM; Charlebois ED; Maciel E; Palaci M; Dietze R
Int J Tuberc Lung Dis; 2006 Jun; 10(6):605-12. PubMed ID: 16776446
[TBL] [Abstract][Full Text] [Related]
24. Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery.
Jensen MK; Fiscella RG
Am J Health Syst Pharm; 2006 Sep; 63(17):1637-40. PubMed ID: 16914634
[No Abstract] [Full Text] [Related]
25. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
[TBL] [Abstract][Full Text] [Related]
26. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
Moshirfar M; Meyer JJ; Espandar L
J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosis.
Kenny DJ; Sefton AM; Brooks TJ; Laws TR; Simpson AJ; Atkins HS
Int J Antimicrob Agents; 2010 Jul; 36(1):87-9. PubMed ID: 20462743
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
Kim JY; Kim SY
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530
[TBL] [Abstract][Full Text] [Related]
29. SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.
Bermudez LE; Kolonoski P; Seitz LE; Petrofsky M; Reynolds R; Wu M; Young LS
Antimicrob Agents Chemother; 2004 Sep; 48(9):3556-8. PubMed ID: 15328125
[TBL] [Abstract][Full Text] [Related]
30. The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty.
Moshirfar M; Marx DP; Kumar R
Cornea; 2005 Oct; 24(7):833-6. PubMed ID: 16160500
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Caballero AR; Marquart ME; O'Callaghan RJ; Thibodeaux BA; Johnston KH; Dajcs JJ
Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
[TBL] [Abstract][Full Text] [Related]
32. Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice.
N T; B N; O O; D D; J B
BMC Complement Altern Med; 2018 May; 18(1):144. PubMed ID: 29724202
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
Adone R; Francia M; Ciuchini F
Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
[TBL] [Abstract][Full Text] [Related]
34. Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only?
Morovic M
Am J Trop Med Hyg; 2005 Nov; 73(5):947-8. PubMed ID: 16282309
[TBL] [Abstract][Full Text] [Related]
35. Prevention of laboratory-acquired brucellosis: significant side effects of prophylaxis.
Maley MW; Kociuba K; Chan RC
Clin Infect Dis; 2006 Feb; 42(3):433-4. PubMed ID: 16392095
[No Abstract] [Full Text] [Related]
36. Pharmacologic considerations for cataract surgery.
Tipperman R
Curr Opin Ophthalmol; 2004 Feb; 15(1):51-5. PubMed ID: 14743020
[TBL] [Abstract][Full Text] [Related]
37. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series.
Moshirfar M; Feiz V; Vitale AT; Wegelin JA; Basavanthappa S; Wolsey DH
Ophthalmology; 2007 Apr; 114(4):686-91. PubMed ID: 17184840
[TBL] [Abstract][Full Text] [Related]
38. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
Kilic S; Dizbay M; Cabadak H
J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
[TBL] [Abstract][Full Text] [Related]
40. Moxifloxacin prophylaxis in neutropenic patients.
von Baum H; Sigge A; Bommer M; Kern WV; Marre R; Döhner H; Kern P; Reuter S
J Antimicrob Chemother; 2006 Oct; 58(4):891-4. PubMed ID: 16880172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
